Emmis Acquisition Corp. (EMIS) Stock Price & Analysis
Emmis Acquisition Corp. (EMIS) rose 0.00% to USD 10.25 as of September 8, 2026 at 13:16 UTC, according to Nexqual real-time market data.
EMIS last closed at USD 10.25; the session ranged USD 10.25–10.25 on volume of 12 shares. Market capitalization is —, with a 52-week range of USD 9.9–10.26 (NGM). Source: Nexqual, September 8, 2026 at 13:16 UTC.
Key Statistics (as of September 8, 2026 at 13:16 UTC)
| Price | USD 10.25 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 10.25 |
| Open | USD 10.25 |
| Day Range | USD 10.25 – 10.25 |
| 52-Week Range | USD 9.9 – 10.26 |
| Volume | 12 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (EMIS)
Nexqual's technical model rates EMIS "STRONG BUY" based on 5 bullish and 0 bearish signals across 128 daily candles, as of September 8, 2026 at 13:16 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 65.1 (neutral) |
| vs SMA50 | Above (USD 10.2) |
| MACD | 0.01 (positive) |
From Emmis Acquisition Corp.'s Latest SEC 10-K Filing (filed 2026-03-27)
Key Strengths & Strategy (as disclosed to the SEC)
- Previously, she was the venture capital and startups lead at Amazon Web Services from January 2020 to October 2023 and the Pre-VC startups and ecosystem lead there from January 2020 to August 2023.
- We believe this focus will allow us to leverage the industry knowledge, operational expertise, and extensive networks of our officers, directors, and affiliates of our sponsor.
- Because we are able to complete our initial business combination using our cash, debt or equity securities, or a combination of the foregoing, we have the flexibility to use the most efficient combination that will allow us to tailor the consideration to be paid to the target business to fit its needs and desires.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| CASIF | CASI Pharmaceuticals, Inc. | USD 0.15 | ▲ 7.14% |
| ATRX | Adhera Therapeutics Inc. | USD 0 | ▲ 0% |
| CVAS | CREATIVE VISTAS INC | USD 0 | ▲ 0% |
| GNTA | Genenta Science S.p.A. | USD 0.96 | ▼ 1.83% |
| BIOM | Biomolecular Life Holdings, Inc. | USD 0.41 | ▼ 14.55% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 13:16 UTC. This page is informational and not investment advice.